Spearman’s correlation between quantitative levels of cfDNA with cancer biomarkers indicated that cfDNA was significantly correlated with ER, PR, TNBC, and TPBC, except HER2, suggesting that cfDNA could be used as a diagnostic and prognostic biomarker for BC. This evidence concerns the gene PGR and breast cancer.